Threshold of evaluation for short stature in a pediatric endocrine clinic: Differences between boys versus girls?

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 1, 2007, Pages 21-26

  Lee, Joyce M ^a,e   Davis, Matthew M ^a,b   Clark, Sarah J ^a,b   Kemper, Alex R ^c,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Evaluation; Sex differences; Short stature; Sub specialty utilization

Indexed keywords

ADOLESCENT; AGE; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; CHILD; CHILD CARE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GROWTH DISORDER; HEALTH CARE UTILIZATION; HUMAN; INFANT; MALE; OUTPATIENT DEPARTMENT; SEX DIFFERENCE; SEX RATIO; SHORT STATURE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HOSPITAL; METABOLISM; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; AGE FACTORS; BODY HEIGHT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DISORDERS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; SEX FACTORS;

EID: 34047251479     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.1.21     Document Type: Article

References (16)

1. Freed GL, Nahra TA, Venus PJ, Schech SD, Wheeler JR. Changes in the proportion and volume of care provided to children by generalists and subspecialists. J Pediatr 2005; 146: 14-19.
2. Forrest CB, Glade GB, Baker AE, Bocian AB, Kang M, Starfield B. The pediatric primary-specialty care interface: how pediatricians refer children and adolescents to specialty care. Arch Pediatr Adolesc Med 1999; 153: 705-714.
3. Singh J, Cuttler L, Shin M, Silvers JB, Neuhauser D. Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. Med Care 1998; 36 (Suppl): AS31-45.
4. Grimberg A, Kutikov JK, Cucchiara AJ. Sex differences in patients referred for evaluation of poor growth. J Pediatr 2005; 146: 212-216.
5. American Medical Association. International Classification of Diseases, 9th revision, clinical modification: ICD-9-CM. United States: American Medical Association; Medicode.
6. Lifshitz F. Pediatric Endocrinology, 3rd Ed. New York: Marcel Dekker, 1996; 1-18.
7. Sperling M, ed. Pediatric Endocrinology. Philadelphia, PA: Saunders, 2002; 217.
8. A SAS Program for the CDC Growth Charts. http://www.cdc.gov/nccdphp/dnpa/ growthcharts/sas.htm. Accessed November 19, 2004.
9. Otters H, van der Wouden JC, Schellevis FG, van Suijlekom-Smit LW, Koes BW. Dutch general practitioners' referral of children to specialists: a comparison between 1987 and 2001. Br J Gen Pract 2004; 54: 848-852.
10. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994; 125: 29-35.
11. Lee PA, Witchel SF. The influence of estrogen on growth. Curr Opin Pediatr 1997; 9: 431-436.
12. Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab 2001; 86: 2364-2368.
13. Finkelstein BS, Singh J, Silvers JB, Marrero U, Neuhauser D, Cuttler L. Patient attitudes and preferences regarding treatment: GH therapy for childhood short stature. Horm Res 1999; 51 (Suppl 1): 67-72.
14. FDA talk paper: FDA approved Humatrope for short stature. http:// www.fda.gov/bbs/topies/ANSWERS/2003/ANS01242.html. Accessed July 7, 2004.
15. Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med 2004; 158: 108-110.
16. Wyatt D. Lessons from the National Cooperative Growth Study. Eur J Endocrinol 2004; 151 (Suppl 1): S55-59.